Crossmark

The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis

Crossref DOI link: https://doi.org/10.1007/s00125-022-05824-0

Published Online: 2022-11-22

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Young, Katherine G. http://orcid.org/0000-0003-2570-3864
McGovern, Andrew P. http://orcid.org/0000-0002-6833-9399
Barroso, Inês http://orcid.org/0000-0001-5800-4520
Hattersley, Andrew T. http://orcid.org/0000-0001-5620-473X
Jones, Angus G. http://orcid.org/0000-0002-0883-7599
Shields, Beverley M. http://orcid.org/0000-0003-3785-327X
Thomas, Nicholas J. http://orcid.org/0000-0003-2513-7022
Dennis, John M. http://orcid.org/0000-0002-7171-732X
License Information

Text and Data Mining valid from 2022-11-22

Version of Record valid from 2022-11-22
More Information

Article History

Received: 11 July 2022

Accepted: 14 September 2022

First Online: 22 November 2022

Change Date: 22 May 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s00125-023-05933-4